Increased level of serum prostaglandin-2 in early stage of esophageal squamous cell carcinoma
Open Access
- 1 January 2014
- journal article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 5 (5) , 956-961
Abstract
Introduction: Prostaglandin-2 (PGE-2), one of the products of cyclooxygenase-2 (COX-2) induced catalysis, may play a critical role in the carcinogenesis of esophageal squamous cell carcinoma (ESCC). We investigated the efficacy of using serum PGE-2 concentration as a biomarker for this cancer...Keywords
This publication has 30 references indexed in Scilit:
- COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancerTumor Biology, 2009
- Early diagnosis of oesophageal cancerBritish Journal of Cancer, 2009
- E Series of Prostaglandin Receptor 2-Mediated Activation of Extracellular Signal-Regulated Kinase/Activator Protein-1 Signaling Is Required for the Mitogenic Action of Prostaglandin E2 in Esophageal Squamous-Cell CarcinomaThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinomaEuropean Journal of Surgical Oncology, 2008
- Epidemiology of oesophagogastric cancerBest Practice & Research Clinical Gastroenterology, 2007
- Letter to the editorHead & Neck, 2007
- The Role of Prostaglandins and Other Eicosanoids in the Gastrointestinal TractGastroenterology, 2005
- New insights into COX-2 biology and inhibitionBrain Research Reviews, 2005
- Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinomaThe Annals of Thoracic Surgery, 2003
- Deleterious effects of prostaglandin E2 in oesophageal carcinogenesisMedical Hypotheses, 1997